Ischaemic heart disease in Behçet's syndrome: a systematic review and meta-analysis

Clin Exp Rheumatol. 2022 Sep;40(8):1497-1503. doi: 10.55563/clinexprheumatol/1shqmz. Epub 2022 Jun 6.

Abstract

Objectives: Behçet's syndrome (BS) has been reported with cardiovascular involvement. It's still unclear that BS is associated with the increased risk of ischaemic heart disease (IHD). We aimed to conduct a meta-analysis concerning the incidence of IHD in BS and identify the relationship between IHD and BS.

Methods: We performed a comprehensive literature search based on PubMed and Embase databases up to 7 July, 2021. Incidence of IHD was calculated by metaproportion. Pooled risk ratio and 95% confidence interval (CI) were calculated using a random-effect, generic inverse variance method of DerSimonian and Laird.

Results: Four studies with 9237 patients with IHD in BS and 40353 controls were identified and included in our meta-analysis. The pooled risk ratio of IHD in patients with BS was 1.30 and achieved statistical significance (95% CI 1.04-1.64). The statistical heterogeneity was low with an I2 of 39% (p=0.18).

Conclusions: In this meta-analysis the presence of BS was associated with an increased risk of IHD. Prospective researches should be done to determine the pathophysiological and prognostic implications of increased IHD in BS.

Publication types

  • Meta-Analysis
  • Systematic Review

MeSH terms

  • Behcet Syndrome* / complications
  • Behcet Syndrome* / diagnosis
  • Behcet Syndrome* / epidemiology
  • Coronary Artery Disease*
  • Humans
  • Incidence
  • Myocardial Ischemia* / epidemiology
  • Myocardial Ischemia* / etiology
  • Prospective Studies
  • Risk Factors